Advertisements


Medtronic initiates clinical study to assess safety of drug-eluting stents

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

A slew of new studies are raising fresh doubts on whether malaria pills should be used to treat the coronavirus, and a top US health agency just warned against widespread use

Chesnot/Getty Images A new clinical study in Brazil raises safety concerns about coronavirus patients taking a high dose of the anti-malaria drug chloroquine. .....»»

Category: topSource: businessinsiderApr 24th, 2020

Emergent BioSolutions initiates Phase 1 clinical study of anti-Zika drug

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 31st, 2018

Clinical study shows safety, efficacy outcomes for Medtronic Resolute Onyx DES

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 23rd, 2018

Myovant"s stock falls after FDA puts partial clinical hold on trial for contraceptive candidate

Shares of Myovant Sciences Ltd. were down 5.7% in premarket trading on Wednesday after the company told investors that the Food and Drug Administration had placed a partial clinical hold on a study assessing an experimental birth c.....»»

Category: topSource: marketwatchMay 19th, 2021

Medtronic announces clinical data from Symplicity Renal Denervation System study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2021

Aspira Women"s Health initiates clinical study for Ovarian Cancer risk detection

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 12th, 2021

Medtronic announces safety, effectiveness results for IN.PACT AV Access study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 20th, 2021

Ionis Pharmaceuticals initiates pivotal clinical study of ION373

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 20th, 2021

Progenity initiates safety, tolerability srudy of Drug Delivery System capsule

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 17th, 2021

Gilead, Galapagos drug fails in Phase 3 clinical study

Shares of Gilead Sciences Inc. were down 0.1% in premarket trading on Thursday, the day after the company said an experimental idiopathic pulmonary fibrosis drug it was developing with Galapagos failed a Phase 3 clinical trial. Shares o.....»»

Category: topSource: marketwatchFeb 11th, 2021

AC Immune initiates clinical study of Parkinson"s disease diagnostic

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 8th, 2021

Biogen"s stock is up 5% after Lilly reports positive data from an Alzheimer"s study

Shares of Biogen Inc. gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about an experimental Alzheimer's disease treatment that is similar to a Biogen therapy under review by the Food and Drug A.....»»

Category: topSource: marketwatchJan 11th, 2021

: Sarepta stock plunges more than 50% after mixed results from drug study

Sarepta Therapeutics Inc. shares lost more than half their value in after-hours trading Thursday, after the company said a drug candidate produced mixed results in a clinical study......»»

Category: topSource: marketwatchJan 7th, 2021

Gilead says shorter remdesivir regimen is effective and drug met main goal in government study

Gilead Sciences Inc. on Wednesday morning announced data from two clinical trials testing its experimental drug remdesivir i.....»»

Category: topSource: marketwatchApr 29th, 2020

TRHC launches simulation study to assess adverse drug events in COVID-19

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 29th, 2020

Gilead"s stock halted, says remdesivir met primary endpoint in government study

Gilead Sciences Inc. said Wednesday morning that a government-run clinical trial evaluating its experimental drug remdesivir in certain COVID-19 patie.....»»

Category: topSource: marketwatchApr 29th, 2020

Axsome Shares Jump 25% on Alzheimer’s Study Results

Clinical trial of AX-05 showed drug reduces patient agitationRelated Stocks: AXSM, LLY, RHHBY, ACIU, MOR, ESALY, BIIB,.....»»

Category: blogSource: gurufocusApr 28th, 2020

AstraZeneca to test diabetes drug in severely ill COVID-19 patients

Shares of AstraZeneca were down 0.9% in trading on Thursday after the British drugmaker said it will conduct a clinical study evaluatin.....»»

Category: topSource: marketwatchApr 23rd, 2020

Incyte, Novartis launch drug study to treat coronavirus complication

Incyte Corp. said Friday it and Novartis AG started a late-stage clinical trial to study a drug meant to treat a serious complication of COVID-19. The biotech company said it was testin.....»»

Category: topSource: marketwatchApr 17th, 2020

NIH starts trial testing safety, effectiveness of hydroxychloroquine

The National Institutes of Health (NIH) said Thursday it started a clinical trial that will test the safety and effectiveness of hydroxychloroquine in more than 500 hospitalized patients with COVID-19. Hydroxychloroquine is a decades-old malaria drug t.....»»

Category: topSource: marketwatchApr 9th, 2020